Market Place
Sourcing Support
AI Transforms Pharma`s Financials Beyond Drug Discovery
11 Feb 2026 //
BIOSPACE
BMS And Evinova Pen Global Development Partnership
09 Feb 2026 //
FIERCE BIOTECH
Evinova, Bristol Myers Squibb Partner To Enhance Clinical
09 Feb 2026 //
BUSINESSWIRE
BMS Beats Again Despite Eliquis And Cobenfy Disappointments
05 Feb 2026 //
BIOSPACE
BMS Turns Focus To New Growth Drivers As Legacy Meds Decline
05 Feb 2026 //
FIERCE PHARMA
BMS Lauds Breyanzi`s Shutout Against Cancer With Soccer Legend
04 Feb 2026 //
FIERCE PHARMA
BMS, J&J Factor In HCP Education Before Milvexian Data Drop
03 Feb 2026 //
FIERCE PHARMA
Bristol Myers Halts Zydus` Biosimilar Cancer Drug Sales
29 Jan 2026 //
ECONOMICTIMES
BMS Snags Top Neuro Researcher From Eisai—Chutes & Ladders
23 Jan 2026 //
FIERCE BIOTECH
BMS pens $850M tumor pact with T-cell engager biotech Janux
22 Jan 2026 //
FIERCE BIOTECH
NICE Recommends Opdivo for Resectable NSCLC Cancer
21 Jan 2026 //
PHARMIWEB
T1D Fund Appoints Teresa Foy, Ph.D. to Advance Therapies
21 Jan 2026 //
PR NEWSWIRE
Scotland Approves Dual Immunotherapy for MMRd/MSI-H mCRC Cancer
20 Jan 2026 //
PHARMIWEB
Scotland Approves Dual Immunotherapy for MMRd/MSI-H mCRC
20 Jan 2026 //
PHARMIWEB
Microsoft, Bristol Myers Advance AI Lung Cancer Detection
20 Jan 2026 //
BUSINESSWIRE
Syngene Expands Research Collaboration With Bristol Myers Squibb
20 Jan 2026 //
ECONOMICTIMES
PRI Files Amicus Brief in SCOTUS Medical Freedom Case
16 Jan 2026 //
PR NEWSWIRE
BMS Initiates Early-Stage Ventures Amid Pharma`s Late-Stage Rush
12 Jan 2026 //
BIOSPACE
Bristol Myers CEO Pledges To `Cast A Broad Net` In Dealmaking
12 Jan 2026 //
FIERCE BIOTECH
Bristol Myers Squibb Reports Phase 3 SCOUT-HCM Trial Success
12 Jan 2026 //
PHARMIWEB
Tempus Achieves Record Total Contract Value Exceeding $1.1 B
11 Jan 2026 //
BUSINESSWIRE
Biotech Showcase Facilitates Investor, Pharma, And Media Access
08 Jan 2026 //
PHARMIWEB
Bristol Myers Squibb at J.P. Morgan`s 44th Healthcare Conference
02 Jan 2026 //
BUSINESSWIRE
Bristol Myers Lines Up Many Launches For India With `AI` Speed
24 Dec 2025 //
ECONOMICTIMES
Bristol Myers Squibb Enhances U.S. Access To Vital Medicines
19 Dec 2025 //
BUSINESSWIRE
BMS’ Cobenfy TV Ad Is Latest Target Of FDA Untitled Letter Spree
19 Dec 2025 //
FIERCE PHARMA
Bristol Myers Squibb To Release Q4 2025 Results On Feb 5, 2026
18 Dec 2025 //
BUSINESSWIRE
Bristol Myers Squibb Launches Ai-Powered `Mosaic` Hub In Mumbai
17 Dec 2025 //
INDPHARMAPOST
Harbour BioMed Signs Antibody Deal with Bristol Myers Squibb
16 Dec 2025 //
PR NEWSWIRE
FDA Grants Priority Review for Opdivo Plus Chemo in Lymphoma
11 Dec 2025 //
PHARMIWEB
BMS & BioNtech Unveil Promising Early Results for TNBC therapy
11 Dec 2025 //
INDPHARMAPOST
Bristol Myers Squibb Announces Dividend Increase
10 Dec 2025 //
BUSINESSWIRE
BioNTech, Bristol Myers Squibb Unveil Positive Phase 2 Results
09 Dec 2025 //
GLOBENEWSWIRE
BMS Shares Targeted Lymphoma Therapy Data at ASH
08 Dec 2025 //
BUSINESSWIRE
BMS`s Breyanzi Is First CAR-T Approved in US for Rare Lymphoma
06 Dec 2025 //
BUSINESSWIRE
Terray Reaches AI Drug Discovery Milestone With BMS
03 Dec 2025 //
BUSINESSWIRE
Bristol Myers Squibb Continues ADEPT-2 Phase 3 Study In AD
03 Dec 2025 //
PHARMIWEB
Bristol Myers Squibb Showcases Hematology Pipeline At ASH 2025
01 Dec 2025 //
BUSINESSWIRE
Bristol Myers Must Face $6.7 B Lawsuit Over Delayed Cancer Drug
01 Dec 2025 //
REUTERS
BMS Joins Citi`s 2025 Global Healthcare Conference
26 Nov 2025 //
BUSINESSWIRE
Bristol Myers Squibb To Host Hematology-Focused Investor Event
24 Nov 2025 //
BUSINESSWIRE
BMS Gets EU Nod To Expand Breyanzi Use In Mantle Cell Lymphoma
24 Nov 2025 //
BUSINESSWIRE
Texas Sues Sanofi, BMS Over `Deceptive` Plavix Marketing
21 Nov 2025 //
FIERCE PHARMA
Bristol Myers Squibb Reveals Accepted Amounts & Pricing Terms
18 Nov 2025 //
BUSINESSWIRE
Update On Phase 3 Librexia ACS Trial
15 Nov 2025 //
BUSINESSWIRE
Evotec Secure BMS Milestone in Protein Degradation IND Acceptance
12 Nov 2025 //
PHARMIWEB
Sarah Cannon & Bristol Myers Squibb Expand Collaboration
12 Nov 2025 //
BUSINESSWIRE
BMS Boosts Cancer Trials With Sarah Cannon`s Platform
12 Nov 2025 //
FIERCE BIOTECH
Bristol Myers Squibb Prices €5B Senior Unsecured Notes
10 Nov 2025 //
INDPHARMAPOST
BMS Builds A `World Of Gratitude` To Honor HCPs In New PSA
10 Nov 2025 //
FIERCE PHARMA
Bristol Myers Squibb Prices €5 Billion Of Senior Unsecured Notes
05 Nov 2025 //
BUSINESS WIRE
Dispatch Bio Inks Clinical Supply Deal With Bristol Myers Squibb
04 Nov 2025 //
BUSINESSWIRE
Bristol Myers Squibb Presents Cardiovascular Portfolio Data
03 Nov 2025 //
BUSINESSWIRE
BMS Announces Cash Tender Offers To Purchase Notes
03 Nov 2025 //
BUSINESSWIRE
Bristol Myers Squibb Posts Q3 2025 Revenues $12.2 Billion
02 Nov 2025 //
INDPHARMAPOST
BMS Removes 2 Clinical Programs From Pipeline
30 Oct 2025 //
FIERCE BIOTECH
Bristol Myers Squibb Unveils Q3 2025 Financial Results
30 Oct 2025 //
BUSINESSWIRE
Cobenfy Delivers OK Debut Year As BMS Works To Ease Nerves
30 Oct 2025 //
FIERCE PHARMA
Enforcement Report - Week of October 29, 2025
29 Oct 2025 //
FDA
BMS, Cabaletta`s CAR T Therapy Shows Promise In Small Lupus Study
28 Oct 2025 //
BIOSPACE
